OptimizeRx OPRX Patent rights, net
Patent rights, net at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept oprx:PatentRightsNet.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's patent rights, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's patent rights, net?
- OptimizeRx (OPRX) reported patent rights, net of $4.43M in Q1 2026.
- What is the long-term trend for OptimizeRx's patent rights, net?
- Over 4 years (2020 to 2025), OptimizeRx's patent rights, net has grown at a 18.2% compound annual growth rate (CAGR), from $2.35M to $4.59M.
- What does patent rights, net mean?
- This represents the unamortized carrying value of intellectual property rights and patents owned by the company. It reflects the capitalized cost of legal protections for proprietary technologies or processes that provide a competitive advantage in the healthcare messaging market. Investors monitor this to assess the value of the company's defensive moat and long-term innovation pipeline.